Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study

Borkowetz, 2015, Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer, BJU Int, 116, 873, 10.1111/bju.13023 Delongchamps, 2013, Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies, J Urol, 189, 493, 10.1016/j.juro.2012.08.195 Sonn, 2014, Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen, Eur Urol, 65, 809, 10.1016/j.eururo.2013.03.025 Siddiqui, 2013, Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059 Habchi, 2014, Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy, Clin Radiol, 69, e120, 10.1016/j.crad.2013.10.018 Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1 De Rooij, 2014, Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis, Am J Roentgenol, 202, 343, 10.2214/AJR.13.11046 Abd-Alazeez, 2014, Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard, Prostate Cancer Prostatic Dis, 17, 40, 10.1038/pcan.2013.43 Simmons, 2017, The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy, Br J Cancer, 116, 1159, 10.1038/bjc.2017.57 Margel, 2018, Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study, J Urol, 187, 1247, 10.1016/j.juro.2011.11.112 Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Weinreb, 2016, PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052 Barzell, 2007, Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate—a 4-year experience, Urology, 70, 27, 10.1016/j.urology.2007.06.1126 Kuru, 2013, Definitions of terms, Processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for enhanced prostate diagnostics, BJU Int, 112, 568, 10.1111/bju.12132 Presti, 2003, Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study, J Urol, 169, 125, 10.1016/S0022-5347(05)64051-7 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Gordetsky, 2016, Grading of prostatic adenocarcinoma: current state and prognostic implications, Diagn Pathol, 11, 25, 10.1186/s13000-016-0478-2 Gayet, 2016, The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review, BJU Int, 117, 392, 10.1111/bju.13247 Cool, 2015, Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy, Am J Roentgenol, 204, 83, 10.2214/AJR.14.12681 Futterer, 2015, Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature, Eur Urol, 68, 1045, 10.1016/j.eururo.2015.01.013 Lau, 2001, Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4, J Urol, 166, 1692, 10.1016/S0022-5347(05)65655-8 Rasiah, 2003, Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma, Cancer, 98, 2560, 10.1002/cncr.11850 Borofsky, 2018, What are we missing? False-negative cancers at multiparametric MR imaging of the prostate, Radiology, 286, 186, 10.1148/radiol.2017152877 Branger, 2017, Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real-life experience, BJU Int, 119, 449, 10.1111/bju.13657 Oto, 2010, Prostate cancer : differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging, Radiology, 257, 715, 10.1148/radiol.10100021 Steiger, 2016, Prostate MRI based on PI-RADS version 2: how we review and report, Cancer Imaging, 16, 9, 10.1186/s40644-016-0068-2 Zhang, 2016, Predicting prostate biopsy outcomes: a preliminary investigation on screening with ultrahigh B-value diffusion-weighted imaging as an innovative diagnostic biomarker, PLoS One, 11, 1 Cornud, 2014, Tumor target volume for focal therapy of prostate cancer—does multiparametric magnetic resonance imaging allow for a reliable estimation?, J Urol, 191, 1272, 10.1016/j.juro.2013.12.006 Turkbey, 2010, Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation, Radiology, 255, 89, 10.1148/radiol.09090475 Rosenkrantz, 2012, Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected, J Urol, 187, 2032, 10.1016/j.juro.2012.01.074 Radtke, 2016, Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen, Eur Urol, 70, 846, 10.1016/j.eururo.2015.12.052